Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -232,012 | -151,257 | -90,957 | -547,029 | -439,495 |
| Depreciation Amortization | 45,327 | 31,159 | 15,366 | 110,878 | 95,226 |
| Income taxes - deferred | N/A | N/A | N/A | -936 | N/A |
| Accounts receivable | 345 | -412 | -4,693 | -4,725 | -6,101 |
| Accounts payable and accrued liabilities | 16,991 | N/A | N/A | 4,771 | -31,099 |
| Other Working Capital | -20,501 | -34,278 | -11,565 | -89,670 | -91,849 |
| Other Operating Activity | 66,469 | 63,013 | 40,328 | 207,126 | 196,168 |
| Operating Cash Flow | $-123,381 | $-91,775 | $-51,521 | $-319,585 | $-277,150 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,660 | -7,660 | -7,622 | -61,893 | -48,240 |
| Net Acquisitions | N/A | N/A | N/A | -5,400 | -5,400 |
| Purchase Of Investment | -328,239 | -255,174 | -191,182 | 4,519 | 3,951 |
| Other Investing Activity | 511 | 262 | 120 | 538 | 538 |
| Investing Cash Flow | $-335,388 | $-262,572 | $-198,684 | $-62,236 | $-49,151 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -329 | -305 | -207 | -897 | -694 |
| Common Stock Issued | 10,317 | 0 | 0 | 84 | 84 |
| Other Financing Activity | -355 | 0 | 0 | -926 | -926 |
| Financing Cash Flow | $9,633 | $-305 | $-207 | $-1,739 | $-1,536 |
| Exchange Rate Effect | 353 | 260 | 74 | -281 | -208 |
| Beginning Cash Position | 605,743 | 605,743 | 605,743 | 989,584 | 989,584 |
| End Cash Position | 156,960 | 251,351 | 399,576 | 605,743 | 661,539 |
| Net Cash Flow | $-448,783 | $-354,392 | $-206,167 | $-383,841 | $-328,045 |
| Free Cash Flow | |||||
| Operating Cash Flow | -123,381 | -91,775 | -51,521 | -319,585 | -277,150 |
| Capital Expenditure | -7,660 | -7,660 | -7,622 | -62,541 | -48,831 |
| Free Cash Flow | -131,041 | -99,435 | -59,143 | -382,126 | -325,981 |